Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Sell
2,521
-97
-4% -$4.52K 0.02% 389
2025
Q4
$127K Sell
2,618
-27
-1% -$1.34K 0.02% 385
2025
Q3
$125K Sell
2,645
-25
-0.9% -$1.21K 0.02% 403
2025
Q2
$129K Sell
2,670
-315
-11% -$16.1K 0.02% 391
2025
Q1
$166K Sell
2,985
-64
-2% -$3.46K 0.03% 330
2024
Q4
$147K Sell
3,049
-1
-0% -$51 0.02% 375
2024
Q3
$176K Sell
3,050
-12
-0.4% -$648 0.03% 330
2024
Q2
$149K Sell
3,062
-24
-0.8% -$1.16K 0.03% 333
2024
Q1
$150K Buy
3,086
+70
+2% +$3.42K 0.03% 327
2023
Q4
$150K Sell
3,016
-72
-2% -$3.52K 0.03% 314
2023
Q3
$166K Buy
3,088
+1,987
+180% +$106K 0.04% 253
2023
Q2
$59.3K Buy
1,101
+302
+38% +$16.3K 0.01% 453
2023
Q1
$43.5K Sell
799
-220
-22% -$10.7K 0.01% 485
2022
Q4
$49.4K Buy
+1,019
New +$44.7K 0.01% 446

Other funds holding SNY

Colonial Trust's SNY Position: Q1 2026 in Review

Colonial Trust reduced its Sanofi (SNY) stake by 3.7% in Q1 2026, selling an estimated $4.52K and leaving 2,521 shares worth $121K. The position accounts for 0.02% of the portfolio, ranked #389.

Colonial Trust first reported a position in SNY in Q4 2022 and has held it in 14 quarters since. The position peaked at $176K in Q3 2024. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Colonial Trust held 2,521 shares of Sanofi worth $121K as of Q1 2026.
  • Colonial Trust sold 97 Sanofi shares in Q1 2026, an estimated $4.52K.
  • Sanofi made up 0.02% of Colonial Trust's portfolio in Q1 2026, its #389 holding.
  • Colonial Trust first reported a position in Sanofi in Q4 2022 and has held it in 14 quarters since.
  • Colonial Trust's Sanofi position peaked at $176K in Q3 2024.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Colonial Trust's 13F filing for Q1 2026, filed 12 May 2026.